Information was received from a healthcare provider (hcp) and a company representative regarding a patient receiving duramorph (5 mg/ml at 0.
7304 mg/day) and marcaine (27.
6 mg/ml at 4.
032 mg/day) via an implanted pump.
The indication for pump use was non-malignant pain.
It was reported by the nurse practitioner that the patient was hospitalized today with hypotension, bradycardia, and was obtunded.
The reporter believed the patient was getting too much intrathecal medication and they wanted the dose decreased.
Per the reporter, the patient was seen 1 month ago at the hospital with similar symptoms, but not as significant and at that time they felt his dosing was too high and they discontinued his chlorthalidone.
The patient had been routinely going in for dosing increases.
Per the reporter, the patient took a lot of antidepressants, was also using ativan 0.
5 mg, and was on lasix.
The emergency overdose procedure and emptying the reservoir were discussed and the reporter stated that theywould prefer to program the pump to a lower dose.
Additional information was received from a company representative who reported that he was called to go to the icu (intensive care unit) because the patient needed his pump turned down.
Per the reporter, he was in the hospital for other medical conditions.
It was unknown if there were any environmental, external, or patient factors that may have led or contributed to the issue.
The pump dose was decreased by 15% per the physician.
It was unknown if the issue was resolved, and it was indicated that the hcp had no further information to provide regarding the event.
|